Since the earliest days of the HIV epidemic, haematological malignancies have been a defining feature of illness caused by the virus; individuals with HIV are living longer and contending with the challenges of treating cancer while on ART, now, work on haematological cancers is providing insights into how a cure for HIV might be achieved. Join Peter Hayward, Editor-in-Chief of The Lancet HIV, and the Series authors as they introduce and explore the findings from this new joint Series on HIV-related haematological malignancies from The Lancet Haematology and The Lancet HIV.
About the Speakers:
- Satish Gopal, National Cancer Institute Center for Global Health, Rockville, MD, USA
- Ariela Noy, Memorial Sloan Kettering Cancer and Weill Medical College, New York, NY, USA
- Thomas S. Uldrick, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- Peter Hayward, The Lancet HIV, London, UK